Philips cuts annual sales outlook as China demand deteriorates further

Philips said on Monday that demand in China slumped significantly in recent months, forcing the Dutch medical devices maker to lower its sales outlook for the year. 

"In the (third) quarter, demand from hospitals and consumers in China further deteriorated, while we continue to see solid growth in other regions," Chief Executive Roy Jakobs said in a statement. 

"China remains a fundamentally attractive growth market for Philips in the long term, with market conditions expected to remain uncertain." 

Philips now expects its comparable sales to grow by only 0.5 per cent to 1.5 per cent in 2024, down from previous forecast of 3 per cent to 5 per cent which it said would still be met in other regions. 

The company, which sells products ranging from toothbrushes to medical imaging systems, is a main competitor of General Electric and Siemens Healthineers. 

The slowdown was most visible in the personal health segment, where sales fell 5 per cent in the third quarter due to a double-digit decline in China. 

The division that sells medical devices to hospitals (Diagnosis & Treatment) saw sales decline by 1 per cent, with "solid growth" outside China, the Amsterdam-based company said. 

Overall, comparable sales were flat at 4.4 billion euros ($4.75 billion), missing the 2.1 per cent growth analysts on average had predicted. 

Adjusted earnings before interest, taxes and amortisation (EBITA) were exactly in line with expectations at 516 million euros, up 13 per cent year-on-year, as lower costs pushed the profit margin up to 11.8 per cent. 

Philips said it expects its full-year core profit margin to come in around 11.5 per cent, the upper-end of its previous outlook.

  (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)